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Abstract
Completion of the Human Papillomavirus (HPV) vaccine series is a national priority. This study 
not only identified correlates of intent to complete the vaccine series and actual series completion, 
but also tested the efficacy of a DVD intervention to promote series completion. Women’s beliefs 
that all three doses reduced cancer risk predicted intent and completion. Intention predicted 
completion, as did the belief that having a friend accompany the woman would promote 
completion. Beyond these effects, women assigned to the intervention were 2.44 times more likely 
than women in the control group to complete the series. Thus, in controlled analyses, a theory-
grounded DVD intervention successfully promoted HPV series completion in a community 
setting. This method of intervention has high translational potential.
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Vaccination against the Human Papillomavirus (HPV), the most common sexually-
transmitted infection, is a primary prevention strategy to protect women against cervical 
cancer (CDC, 2012). Annually, cervical cancer affects approximately 12,000 women in the 
United States and results in death for another 4,200 women (ACS, 2012). Women residing 
in rural and other medically underserved communities are disproportionately burdened by 
cervical cancer incidence and mortality (Freeman & Wingrove, 2005). Despite the fact that 
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these women stand to benefit most from HPV vaccination, evidence suggests that HPV 
vaccination diffusion in the United States has been inequitable, HPV vaccination goals are 
not being met, and adherence to the full regimen is sub-optimal (Dorell, Stokley, Yankey, & 
Markowitz, 2011; Williams et al., 2012). Importantly, clinical evidence supporting vaccine 
efficacy to prevent HPV infection, pre-cancerous cervical lesions, and cervical cancer is 
based on completion of the entire three-dose regimen (Markowitz et al., 2007).
Young women 18–26 years old should be considered a priority population for HPV 
vaccination, considering their vaccination rates lag behind that of adolescent females. 
Whereas the national vaccination rate for adolescent females aged 13–17 is 48.7% (Dorell et 
al., 2012), vaccination rates for young women are estimated at 21% (Williams et al., 2012); 
regional variation in uptake ranges from 9% to 49% (Dempsey, Cohn, Dalton, & Ruffin, 
2011). The few regional studies reporting three-dose completion rates indicate that rates 
range from as low as 2% to high as 47%, with disparities observed among African 
Americans, rural women, those covered by public insurance, and females living in 
educationally-disadvantaged neighborhoods (Chao, Velicer, Slezak, & Jacobsen, 2009; 
Crosby, Casey, Vanderpool, Collins, & Moore, 2011; Dempsey et al., 2011). For women 
completing all three doses, many fail to complete the series within the six-month protocol 
(Dempsey et al., 2011).
Lack of vaccination in young women represents a missed opportunity, given that this age 
group is burdened by the higest prevalence rate of HPV infection among all age groups 
(Dunne, Unger, & Sternberg, 2007). Many of these young women were not affored 
opportunities to receive the vaccine as adolescents and were not targeted by pharmaceutical 
companies’ marketing campaigns (Jain et al., 2009). Finally, these women do not qualify for 
the Vaccines for Children program and are often under- or uninsured, making them 
responsible for substanial out-of-pocket healthcare costs (Dempsey et al., 2011; Jain et al., 
2009).
To date, much of the HPV vaccination-related research has solely focused on identifying 
predictors of vaccine acceptability, intent to vaccinate, and/or vaccine initiation without 
examining adherence to the full dosing schedule (Allen et al., 2010; Brewer et al., 2011; 
Bynum, Brandt, Sharpe, Williams, & Kerr, 2011; Chao, Velicer, Slezak, & Jacobsen, 2010; 
Lechuga, Swain, & Weinhardt, 2011; Reiter, 2009; Teitelman et al., 2011; Katz et al., 2010; 
Vanderpool, Casey, & Crosby, 2011). Past research examined different theories of health 
behavior as explanatory for variation in HPV vaccine acceptance. For example, Allen and 
colleagues (2009) used the transtheoretical model (Prochaska, 2008) to assess the stage of 
adoption of the HPV vaccine, the theory of reasoned action (Ajzen & Fishbein, 1980), and 
social cognitive theory (Bandura, 2004) to explain barriers to vaccine uptake. Constructs 
from the health belief model (Rosenstock, 1974) have also been reported extensively in the 
HPV vaccination literature (Allen et al., 2009; Bennett, Buchanan, & Adams, 2012; Brewer 
& Fazekas, 2007; Gerend & Shepherd, 2012; Katz et al., 2010; Krawczyk et al., 2012a; 
Krawczyk et al., 2012b; Teitelman et al., 2011).
In particular, the theory of planned behavior (TPB; Ajzen & Fishbein, 1980) has 
successfully predicted HPV vaccination intentions and vaccine uptake (Bennett et al., 2012; 
Vanderpool et al. Page 2













Gerend & Shepherd, 2012). This theory suggests that constructs such as attitude toward the 
behavior, subjective norms, perceived behavioral control, and intention to perform the 
behavior are the primary mechanisms for behavior change, including adherence (Ajzen & 
Fishbein, 1980; Bennett et al., 2012). Specifically, the subjective norms construct has 
received a great deal of attention in the HPV vaccine-related literature as a predictor of 
intention to vaccinate, as well as vaccine uptake (Allen et al., 2010; Bennett et al., 2012; 
Gerend & Shepherd, 2012; Juraskova et al., 2011; Kahn, Rosenthal, Hamann, & Bernstein, 
2003; Krawczyk et al., 2012b; Teitelman et al., 2011).
Beyond understanding the theoretical underpinnings of a health behavior, there is value in 
developing interventions based on previous assessments of the target population. Consider 
the women who reside in the mountainous region of Appalachian Kentucky in the United 
States. These women shoulder a disproportionate burden of cervical cancer while also 
experiencing poor socioeconomic conditions, lower Pap testing rates, geographic isolation, 
and limited access to healthcare (ARC, 2008; Hopenhayn, King, Christian, Huang, & 
Christian, 2008; Huang et al., 2002; Wingo et al., 2008). From 2005–2009, the five-year 
cervical cancer incidence rate in this region was notably higher than the rest of the country 
(9.85 per 100,000 vs. 8.0, respectively; KCR, 2012; NCI, 2012). Cervical cancer mortality 
rates are 45% higher in Appalachian Kentucky (KCR, 2012; NCI, 2012). Approximately one 
in five women in eastern Kentucky has not had a Pap test in the past three years (KDPH, 
2008). The majority of counties in Appalachian Kentucky are designated as healthcare 
professional shortage areas (HRSA, 2012), and all but three counties are considered 
distressed or at-risk by the Appalachian Regional Commission on the basis of federal 
unemployment, income, and poverty indicators (ARC, 2012).
There is substantial need to address cervical cancer prevention in this rural, medically 
underserved population. In response, we conducted multiple quantitative and qualitative 
studies related to HPV vaccination behaviors. Our first effort involved recruiting 495 young 
women in Appalachian Kentucky into a women’s health study (Crosby et al., 2011; Mills, 
Vanderpool, & Crosby, 2011; Vanderpool et al., 2011; Vanderpool, Crosby, Casey, & Bates, 
2010). The HPV vaccine was offered at no cost. Young women 18–26 years of age were 
provided with vouchers for the full series and were encouraged to initiate the series in the 
clinic upon enrollment. Of 246 women recruited from rural health clinics, only 45% initiated 
dose one. Furthermore, only 14% of those who received dose one returned for dose two, and 
only 5% received dose three (Crosby et al., 2011). Through this work, we learned that access 
and free vaccination were not sufficient to help women overcome barriers to series 
completion. Our qualitative research suggested that young rural women report barriers to 
vaccination, including normative social influences (especially maternal and peer), 
insufficient knowledge, negative (even stigmatized) or ambivalent attitudes toward 
vaccination, questions concerning vaccine safety and efficacy, and barriers such as cost and 
anticipated vaccine pain (Cohen et al., in press; Head & Cohen, 2012; Mills, Head, & 
Vanderpool, in press).
Because of the cervical cancer burden and low rates of HPV vaccination in Appalachian 
Kentucky, as well as the fact that there have been few health communication studies that 
have assessed variables predicting completion of all three HPV vaccine doses among young 
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women (Allen et al., 2010; Chao, Slezak, Coleman, & Jacobsen, 2009; Dempsey et al., 
2011; Katz et al., 2010) or intervened on full series completion, we designed a randomized 
controlled trial to test a theory-grounded intervention targeted to the unique needs of this 
rural population of young women. Accordingly, the purpose of this study was twofold. First, 
the study used the TPB to identify correlates of positive intent to complete the three-dose 
series and actual series completion among a sample of women, ages 18–26, residing in 
Appalachian Kentucky. We hypothesized that women intending to complete the series, as 
well as actually completing all three doses, would be more likely to a) have supportive HPV 
vaccination attitudes, b) have norms supporting vaccine completion, and c) report perceived 
behavioral control beliefs favoring series completion. We also hypothesized that positive 
intention to complete the three-dose series would predict adherence to the full vaccine 
regimen. Second, and more importantly, the study tested the efficacy of a field-based DVD 
communication intervention designed to promote series completion. We hypothesized that 
women randomized to the DVD-arm would be significantly more likely than those receiving 
standard-of-care to complete the vaccine series, even after controlling for baseline level of 
intent to complete the series as well as controlling for other predictor variables 
corresponding with the TPB.
Method
Participants and Processes
In order to deliver an intervention immediately following the first dose of a vaccine and 
conduct a randomized trial of vaccine completion, it is necessary to begin with a population 
being newly vaccinated with dose one. From 2010–2011, we launched a social marketing 
campaign informed by Rogers’ (1995) diffusion of innovations designed to promote uptake 
of the first HPV vaccine dose (Cohen et al., in press). The social marketing campaign 
targeted young women from an eight-county catchment area of Appalachian Kentucky in the 
United States by promoting the availability of free HPV vaccines for 18–26 year old women. 
Research nurses provided free vaccination (dose one) at local health departments, medical 
clinics, community colleges, outdoor festivals, Wal-Mart stores, businesses, and women’s 
homes. To be eligible to receive dose one, women had to be 18–26 years old, not be 
pregnant, not previously vaccinated against HPV, and not have had prior vaccine reactions 
that prevented HPV vaccination. All vaccinated women received a standard-of-care 
pamphlet about the risks and benefits of the vaccine published by the Centers for Disease 
Control and Prevention.
Following uptake of dose one, women were asked to participate in a research study (see 
Figure 1 for study design). All women agreed to participate. Three primary reasons explain 
this success: The women received dose one of the vaccine for free; the research nurses were 
from the women’s community; and women received a free t-shirt as part of the social 
marketing campaign. In essence, the research nurses’ small overture to participate in a 
research study was viewed favorably by our study participants. After providing written 
informed consent, women were asked to complete a baseline survey using audio-computer-
assisted self-interviewing (ACASI) administered on a laptop computer. Intervention or 
comparison group allocations were assigned at the end of the ACASI using a random 
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number sequence. Investigators and research nurses in the field were blinded to the 
allocation sequence. All research activities were approved by the University of Kentucky 
Institutional Review Board, including compensating women with $25 gift cards upon 
baseline survey completion.
Intervention
Women randomized to the intervention arm watched a 13-minute educational DVD, entitled 
“1-2-3 Pap,” from a laptop computer, using stereo headphones. Design and development of 
the DVD was guided by the information, motivation, behavioral skills model (IMB; Fisher 
& Fisher, 2002), which has been widely used in HIV prevention projects (Fisher & Fisher, 
2002), and more recently, improving adherence to health recommendations (Ferrer, Morrow, 
Fisher, & Fisher, 2010). The IMB was developed as a well-validated, comprehensive 
framework for integrating commonly used health behavior constructs into a single model for 
message design. The IMB specifies a three-phase process for intervention development, 
including eliciting the information, motivation, and skills factors important to the target 
behavior. Accordingly, DVD content was based on formative research with young women 
from Appalachian Kentucky regarding their HPV vaccination and Pap testing behavior 
(Cohen et al., in press). The resultant intervention design included specific health 
information relevant to the target health behavior and specific to the population; personal 
motivation and normative cues; and skills training to increase efficacy (Fisher, Fisher, & 
Harman, 2003). Specifically, the content of the DVD included risks of HPV and HPV-
related harm, encouraged women to consider the benefits of vaccination and Pap tests, 
informed patients about the necessity to complete the vaccine series, motivated series 
completion, enhanced self-efficacy for series completion, and helped women overcome 
personal obstacles to series completion. The DVD was organized into 10 broad message 
segments (see Figure 2 for thematic overview) and included a roughly one-minute opening 
and closing with cues to action delivered by a local Appalachian, young female TV news 
reporter. The DVD footage also featured young women (proscriptive models), a nurse 
practitioner, and a physician, all of whom were from the target community. The young 
women and healthcare providers discussed eastern Kentucky cervical cancer statistics, HPV 
infection and its relation to cervical cancer, HPV vaccination, and Pap testing. It used a 
mixture of video footage, narrative and informational content sequences, still shots, and 
written captions. Recording and editing occurred at a local studio.
Study Measures
The baseline survey was informed by previous research (Brewer & Fazekas, 2007; Crosby et 
al., 2011; Crosby, Schoenberg, Hopenhayn, Moore, & Melhan, 2007) and included specific 
questions addressing TPB constructs. Wording of survey items and their response options 
are listed in Table 1. These measures were initially used to identify TPB correlates of 
positive intent to complete the three-dose vaccine series, as well as actual series completion. 
These measures were also controlled for during analysis assessing the intervention effect on 
series completion. Women’s vaccination dates and series completion were tracked by 
medical record review for up to nine months past the initial vaccine dose. This article 
includes all records that were complete according to study protocol by June 30, 2012; 
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additional medical record review and checking for data completion and accuracy will 
continue.
Data Analysis
For the first purpose of the study, continuous TPB correlates of young women’s intent to 
complete the vaccine series were evaluated by using independent groups t tests at the 
bivariate level. Next, dichotomous TPB correlates of intent, as well as two control variables 
(whether women reported ever having had penile-vaginal sex and whether they had ever 
been told they had an abnormal Pap test) were evaluated using chi-square tests at the 
bivariate level. Subsequently, a hierarchical logistic regression model was constructed using 
two blocks. The first block contained the two control variables if determined significant at p 
≤. 10. The second block used a forward stepwise entry procedure to test all TPB continuous 
and dichotomous correlates significant at a screening level of p ≤. 10 at the bivariate level 
for their independent association with intent. At the multivariate level, significance was 
established by 95% confidence intervals and their respective p values.
For the second purpose of the study, the same bivariate procedures used in the cross-
sectional study of intent were applied to vaccine series completion. Subsequently, a 
hierarchical logistic regression model was constructed using three blocks. The first block 
contained the two control variables if determined significant at p ≤. 10, in addition to 
containing intent as a predictor variable. The second block used a forward stepwise entry 
procedure as before and contained TPB continuous and dichotomous variables significant at 
a screening level of p ≤. 10 in the bivariate analysis. The third block contained only the 
independent variable (intervention vs. control). Multivariate significance was established by 
95% confidence intervals and their respective p values. All analyses were conducted using 
SPSS version 19.0.
Results
From 2010–2011, 345 women received dose one of the HPV vaccine through the social 
marketing campaign. Subsequent to receiving the vaccine, 100% of the women agreed to 
participate in the randomized controlled trial; one woman agreed to participate, but did not 
have time to participate in the survey/passively refused to complete the survey. The final 
sample for analysis was 344 women. The mean age was 22 years (SD = 2.4); the sample was 
primarily non-Hispanic White (94%), reflecting 2010 Census data for this region (Center, 
2012). Ninety percent of the women had lived in southeastern Kentucky for over five years. 
Only one-quarter (25.6%) were employed full-time; however, almost half (48.0%) reported 
some college as their highest level of education. Thirty percent of the women were married 
and 39.0% reported having children at home. The sample was sexually experienced, with 
93.9% reporting they had ever had penile-vaginal sex; half the sample (49.3%) reported 
current birth control use. Almost half of the women (46.0%) reported ever having an 
abnormal Pap test, 21.8% had been told by a medical provider that they have a sexually-
transmitted disease, and 15.7% had been told they have HPV.1
Positive intent to complete the vaccine series was indicated by 64.3% of the women (n = 
220). Just over one-third (37.8%) of the sample completed the three-dose series. 
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Randomization produced roughly equivalent sized groups, with 178 (51.7%) randomized to 
the intervention condition and 166 (48.3%) randomized to the standard-of-care condition. Of 
note, randomization did not yield equivalence regarding intent. Positive intent was indicated 
by 58.2% of those randomized to the intervention condition and 70.9% in the control 
condition (p = .014). Nearly half of the women (43.3%) randomized to the DVD 
intervention completed the three-dose series, whereas 31.9% of women assigned to the 
comparison group completed the series, for a percent relative difference of 35.7% (p = .03).
Bivariate Findings
Table 2 displays the bivariate findings from the cross-sectional study of positive intent; there 
were no differences by group assignment for any of the continuous-level or dichotomous 
correlates (data not shown). As hypothesized, the majority of assessed TPB correlates were 
significantly associated with intent (p ≤. 10), each in the anticipated direction. For example, 
women with positive intent to complete the vaccine series were more likely to agree that 
getting all three doses of the HPV vaccine would decrease their chance of getting cervical 
cancer (i.e., supportive vaccine attitudes). Likewise, women with positive intent were less 
likely to report childcare, transportation, and work as barriers to series completion. 
However, inconsistent with our supportive norms hypothesis, women with positive intent 
were less likely to agree with statements that their mother and father encouraged 
vaccination. The control variables, history of an abnormal Pap (p = .001) and having had 
previous sexual intercourse (p = .001), were both significantly associated with positive 
intent to complete the vaccine series (data not shown).
Table 3 displays the bivariate findings for actual vaccine series completion. As shown, five 
of eight TPB predictors assessed at the continuous level were significantly associated with 
series completion (p ≤. 10). For example, women who completed the vaccine series were 
more likely to agree that the HPV vaccine will reduce the number of cervical cancer case 
(i.e., supportive vaccine attitudes). Two dichotomous variables, transportation and work 
schedule, achieved significance as would be expected; in other words, those who did not 
complete the vaccine series were more likely to report that these barriers would prevent their 
return for subsequent doses. Inconsistent with our subjective norms hypothesis, however, 
neither father encouragement to complete the vaccine series nor peer vaccination behaviors 
were significantly correlated with series completion. Of the two control variables, history of 
an abnormal Pap was significantly correlated with series completion (p = .03), while history 
of previous sexual intercourse was not (p = .664; data not shown).
Multivariate Findings
Table 4 displays the results of the two-block model regressing intent on the assessed 
correlates. The model fit the data well, χ2 (8) = 135.32, p = .001. As shown, of the two 
control variables that were forced into block one, both the experience of ever having an 
abnormal Pap test result (p = .002) and having had previous sexual intercourse (p = .026) 
1The HPV vaccine is not therapeutic for existing HPV infection or cervical abnormalities; however, women with a history of HPV 
infection and/or an abnormal Pap are still eligible for HPV vaccination to help prevent against infection with HPV virus types not 
already acquired (Markowitz et al., 2007).
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were significantly associated with intent. Six of the correlates retained multivariate 
significance in block two, and each was associated with intent in the anticipated direction, 
with the exception of father encouragement, which was consistent with the bivariate 
findings.
Table 5 displays the results of the three-block model regressing series completion on the 
predictor variables assessed at baseline. The model fit the data well, χ2 (5) =52.97, p = .001. 
As hypothesized, positive intent was a strong predictor of series completion, with those 
indicating positive intent being about 2.1 times more likely to complete the series (p = .016). 
The one control variable, ever having an abnormal Pap test result, failed to achieve 
multivariate significance despite being forced into block one. Only two of the variables 
entered in block two achieved multivariate significance. Women indicating a belief that all 
three doses would reduce their risk of cervical cancer were 1.5 times more likely to 
complete the series than those not having this attitude (p = .001). Also, women indicating 
that they would be more likely to complete the series if a friend went with them were about 
1.5 times more likely to complete the series than those not indicating this facilitating factor 
(p = .011). Most importantly, women randomized to the intervention were 2.44 times more 
likely to complete the vaccine series than those assigned to the standard-of-care condition (p 
= .001).
Discussion
To our knowledge, this is the first communication intervention trial to promote completion 
of the three-dose HPV vaccine series in a community setting. Previous intervention studies 
have focused exclusively on college students’ HPV vaccine knowledge, intentions, and 
initiation using different educational approaches (Hopfer, 2012; Krawczyk et al., 2012a; 
Leonard, Kola, & Walsh, 2011). Alternatively, our DVD-based intervention to improve 
vaccine adherence was conducted in a real-world setting, using nurse providers working in a 
challenging social-cultural environment.
As posited by the TPB, intention was a strong predictor of completing the three-dose 
vaccine regimen among this sample of Appalachian Kentucky women. Previous research 
suggests that intention is the strongest correlate of HPV vaccination uptake among young 
women (Gerend & Shepherd, 2012; Juraskova et al., 2011). Although intention is a 
meaningful predictor of health behavior, it often falls short in fully explaining behavioral 
outcomes (Armitage & Conner, 2001; Webb & Sheeran, 2006). Beyond intention to 
vaccinate, our data demonstrate that a field-based DVD intervention can have an equally 
strong effect on future behavior. In essence, the effect of the DVD was robust given that the 
model was constructed to preferentially allow a large number of other variables to explain 
the variance in series completion. Although this study is the first to examine the outcome of 
adherence, this effect size is consistent with the findings of Hopfer’s (2012) “combined” 
peer-expert video intervention in improving vaccine acceptance.
Impressively, 31.9% of the comparison group achieved series completion while only 
receiving standard-of-care procedures, including an informational HPV vaccine brochure 
and reminder telephone calls for doses 2 and 3. This vaccine series completion rate is lower 
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than Chao and colleagues’ (2009) research in southern California (47.1%); however, women 
in that study were followed over a two-year period and were part of a managed care 
insurance plan with a large network of primary care providers. The rate in our study is 
substantially higher than Dempsey et al.’s (2011) research in Michigan (10%) among 19–26 
year old women and the previous Crosby et al. (2011) study (clinic-recruited sample 4.5%), 
which was conducted with a similar population of medically underserved women in 
Appalachian Kentucky. Our findings may serve as an example for practitioners in medically 
underserved communities. Specifically, working with manufacturer reimbursement 
programs to provide vaccines at low or no cost and following standard-of-care procedures 
that include follow-up phone call reminders and community-based vaccination clinics can 
optimize HPV vaccination adherence rates.
The bivariate data predicting intention to vaccinate were intriguing. These data partially 
supported two TPB-related hypotheses examining intent to complete the series outcome: 
positive attitudes toward HPV vaccination and access to care barriers (as viewed through the 
lens of perceived behavioral control). One unique finding was the inverse relationship 
between parental encouragement and intention to vaccinate. One possible explanation is that 
because these women had already received dose one, their reported belief that a parent did 
not encourage vaccination actually strengthened their existing intention to complete the full 
dosing regimen (a possible reactance effect; Brehm & Brehm, 1981).
Additionally, in the multivariate model, women reporting the experience of an abnormal Pap 
test were three times as likely to report positive intent to complete the vaccine series, 
suggesting these women may experience increased perceived susceptibility to cervical 
cancer and desire to take proactive steps to prevent the disease. Clinicians should consider 
an abnormal Pap test as an opportunity to educate young women about the benefits of the 
HPV vaccine (Kepka, Berkowitz, Yabroff, Roland, & Saraiya, 2012). Believing that three 
doses of the vaccine reduces personal cervical cancer risk and reduces incidence of cervical 
cancer was also predictive of positive intent to complete the vaccine series in the final 
model. Similarly, lack of scheduling barriers predicted positive intent. These data suggest 
the benefits of including vaccine efficacy data related to the prevention of pre-cancerous 
cervical lesions and cervical cancer, as well as strategies for overcoming common barriers to 
vaccination in persuasive messages.
Bivariate data were mixed in offering support of our hypotheses relative to predicting series 
completion. Although having a friend accompany the woman for subsequent doses and 
favorable perceptions of vaccine efficacy significantly predicted completion, perceptions of 
paternal encouragement and peer vaccination behaviors were not significant. As expected, 
barriers of transportation and work schedule were significantly associated with series 
completion; however, the barrier of childcare was not.
The final multivariate model did not support parental influence or peer behaviors as 
significant predictors of series completion. Several studies have suggested that normative 
social influence (particularly maternal influence and health care providers) predicts 
vaccination series initiation (Kester, Zimet, Fortenberry, Kahn, & Shew, 2012; Krieger, 
Kam, Katz, & Roberto, 2011; Krieger, Katz, Kam, & Roberto, 2012). However, our study 
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population had already initiated the vaccine series; therefore, parental influence may not be 
as relevant. Related, parental influences may fade or become less salient for young women 
making health decisions as adults (Teitelman et al., 2011). Prescriptive norms may be more 
meaningful for adolescent audiences given that parental permission is legally required for 
vaccination.
These findings suggest that the TPB offers more limited explanatory power for predicting 
behavioral adoption over time and that studying series completion as distinct from initial 
vaccine uptake and intention to receive three doses of the vaccine is an important area for 
scholarly consideration (Dempsey et al., 2011). Our findings show that potential barriers to 
and facilitators of series completion are quite different. There is no “one-sized fits all” 
approach to encouraging vaccination uptake and series completion. Rather, communication 
interventions should differentiate persuasive strategies appropriate to improving uptake and 
improving series completion in target populations sharing similar socio-cultural beliefs and 
barriers to vaccination.
Limitations
There are noted limitations to our research. We recognize the cross-sectional nature of the 
baseline survey does not allow for measuring temporal changes in health-related attitudes 
and beliefs, the influence of subjective norms, perceived behavioral control, and behavioral 
intentions. An alternative approach would examine differences in key TPB variables 
between the comparison and intervention groups at doses 2 and 3, in addition to baseline/
dose 1. Moreover, there may be other theoretical constructs, structural barriers, and cultural 
practices that are unaccounted for in our analysis and participants may have experienced 
difficulties in recalling past sexual health experiences. Because ours was a community-based 
study, we did not include a probability sample of patients. However, random assignment of 
participants to each condition was designed to ensure the translatability of the intervention 
effects to similar populations.
Despite these limitations, our study focused on improving health equity and reducing 
cervical cancer disparities among a high-risk population of young women residing in the 
Appalachian Mountains of eastern Kentucky. Women in this medically underserved region 
are disparately burdened by cervical cancer compared to other Kentucky women and the 
general female population residing in the United States. These findings of significant 
improvements in series completion after the DVD-based intervention are robust, as they 
were achieved in comparison to an idealized standard-of-care protocol. One limitation to 
external validity is that the vaccine was provided at no cost; however, in medically 
underserved communities similar to Appalachian Kentucky, providers can be reimbursed for 
vaccine costs through manufacturers’ vaccine assistance programs, and the vaccine can 
remain free to women.
Areas for Future Research
Clearly, the DVD production process should be repeated with other populations to create 
effective, appropriate, and translatable communication strategies. Notably, our theory-based 
DVD was guided by information gathered from formative research conducted in the target 
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community (Cohen & Head, in press; Head & Cohen, 2012). Similar processes of formative 
research used for this study could garner insights into the appropriate substitution of local 
data, expert, and peer narratives. Future research may also consider appropriate ways to 
target messages to other groups. If our video were shown to adolescent girls, messages 
related to Pap testing, which may not be appropriate for females under age 18, could be 
excluded from the video. Alternatively, key message components could be maintained and 
video footage re-shot for use with males because they are now eligible for the HPV vaccine 
(Dunne et al., 2011).
In an era of more “personalized” medicine, educational interventions at the point of clinical 
services may become routine. Future research may also consider how brief clinical 
assessments of individual patient’s barriers to vaccination (and adherence) may be used to 
create tailored digital educational messages to enhance vaccination schedule adherence. 
Given the Affordable Care Act’s incentives for improving digitization of medical records, 
future research also may consider how digital educational materials can be integrated into 
the electronic medical record and patient education system. The digital video format ensures 
the fidelity of the message, supports potential integration into existing clinic resources, and 
is compatible with delivery in community settings (e.g., delivered via iPad, portable DVD, 
kiosk, laptop, or desktop computer), provided equipment security and patient privacy 
concerns are addressed.
Finally, future research may consider how training nurse practitioners and community health 
workers may be used to improve the delivery of vaccinations in medically underserved 
communities. For example, training staff to assist with pharmaceutical companies’ 
reimbursement paperwork could serve as a cost-effective measure to obtaining free or low-
cost vaccine supplies for the provider, as well as eliminate patient costs.
Conclusions
A theory-grounded DVD education intervention was successful in improving HPV 
vaccination completion rates. Our approach has the potential to be adapted and replicated 
with other populations of women, including other rural communities and African American 
and Hispanic populations; these populations also are recognized for cervical cancer 
disparities and share many similarities with our target population, such as low 
socioeconomic status, limited access to care, and poor living environments (Freeman & 
Wingrove, 2005). As advocated by Glasgow and colleagues (2004), ultimately, the long-
term goal of this evidence-based intervention is widespread dissemination; in fact, 
dissemination has been a priority since conceptualization of the study. For decades, there has 
been a documented chasm between research and public health practice (Green, Ottoson, 
García, & Hiatt, 2009; IOM, 2001). An intervention such as ours can be can be modified to 
other populations, can be delivered in a variety of non-clinical settings, and requires few 
time, staff, and organizational resources to implement. Indeed, it could become routine 
clinical practice to show the video to women immediately after receiving dose one of the 
HPV vaccine.
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Findings also suggest the potential for translating this approach to other vaccination contexts 
in which adherence to a multiple dosage regimen is necessary (e.g., Hepatitis B; H1N1 for 
children). Theory-based communication interventions designed to overcome barriers to 
dissemination from the beginning (Glasgow, Marcus, Bull, & Wilson, 2004) and promote 
successful translation from research to practice (Schoenwald & Hoagwood, 2001) help to 
make an immediate impact on population-level cancer incidence, morbidity, and mortality.
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Table 1
Study Measures
Construct Survey Question Response Options
Attitudes Do you feel that HPV vaccinations will help some women prevent 
pain, possibly even death by preventing cervical cancer?
6 point agreement scale; DK, Refusal, 
N/A
I feel that if I get all three shots of the HPV vaccine that I will 
decrease my chances of getting cervical cancer.
5 point agreement scale; DK, Refusal, 
N/A
Do you feel that HPV vaccinations will reduce the number of cases 
of cervical cancer?
6 point agreement scale; DK, Refusal, 
N/A
Subjective Norms Have any of your friends been vaccinated against HPV? Yes, No, DK, Refusal, N/A
Do you have friends who have failed to take doses 2 and 3? Yes, No, DK, Refusal, N/A
I would be much more likely to get dose 2 and dose 3 of the 
vaccine if my father encouraged me to do so.
5 point agreement scale; DK, Refusal, 
N/A
I would be much more likely to get dose 2 and dose 3 of the 
vaccine if my mother encouraged me to do so.
5 point agreement scale; DK, Refusal, 
N/A
I would be much more likely to get dose 2 and dose 3 of the 
vaccine if a friend went with me.
5 point agreement scale; DK, Refusal, 
N/A
Perceived Behavioral Control Would childcare prevent you from getting dose 2 and 3? Yes, No, DK, Refusal, N/A
Would your work schedule prevent you from getting dose 2 and 3? Yes, No, DK, Refusal, N/A
Would transportation prevent you from getting doses 2 and 3? Yes, No, DK, Refusal, N/A
I would be much more likely to get dose 2 and dose 3 of the 
vaccine if a health care provider called to remind me.
5 point agreement scale; DK, Refusal, 
N/A
I would not get dose 2 and dose 3 of the vaccine if I had to make a 
special appointment.
5 point agreement scale; DK, Refusal, 
N/A
Intention Do you intend to get all three HPV vaccine shots? Yes, No, DK, Refusal, N/A
Note. DK=don’t know; N/A=not applicable.
a
Don’t know, refusal, and not applicable responses were recoded as missing.
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Table 2
Correlates of Positive Intent to Complete the Three-Dose HPV Vaccine Series (N = 344)
Mean among those with 
negative intent
Mean among those with 
positive intent t p value
Continuous-level Correlatesa
3 doses decreases my cervical cancer riskb 2.33 0.99 9.50 .0001
Vaccine prevents cervical cancer pain and deathc 2.05 1.78 2.29 .02
HPV vaccine will reduce number of cervical cancer 
casesc 2.11 1.26 7.77 .0001
Provider phone call reminder helpfulb 2.12 1.28 5.62 .0001
Would not return if special appointmentb 2.72 2.87 1.24 .22
Would return if friend came with meb 2.84 2.36 3.56 .0001
Father encourages vaccine completionb 1.27 1.77 2.59 .01
Mother encourages vaccine completionb 1.06 1.40 3.82 .0001
Dichotomous Correlatesd % Negative intent % Positive intent p value
Childcare would prevent return
 Yes 68.2+ 31.8 .001
 No 33.4 66.6
Transportation issues would prevent return
 Yes 54.5+ 45.5− .0001
 No 29.7 70.3
Work schedule would not prevent return
 Yes 62.5+ 37.5− .0001
 No 24.2− 75.8+
Friends have been vaccinated
 Yes 38.9 61.1 .50
 No 42.8 57.2
Friends failed to complete full vaccine series
 Yes 36.1 63.9 1.00
 No 36.1 63.9
a
Lower scores represent greater agreement with the statement
b
5 point agreement scale
c
6 point agreement scale
d
+ represents significantly higher frequencies based on standardized residual (≥2 or ≤ −2); - represents significantly lower frequencies based on 
standardized residual (≥2 or ≤ −2).
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Table 3
Correlates of Vaccine Series Completion (N = 344)
Mean for series non-completers Mean for series completers t p value
Continuous-level Correlatesa
3 doses decrease my cervical cancer risk a 1.72 0.95 5.85 .0001
Vaccine prevents cervical cancer pain and deathc 1.90 1.84 .54 .59
HPV vaccine will reduce number of cervical cancer 
casesc 1.74 1.27 4.82 .001
Provider phone call reminder helpfulb 1.74 1.33 2.83 .005
Would not return if special appointmentb 2.79 2.88 .76 .44
Would return if friend came with meb 2.72 2.22 3.70 .001
Father encourages vaccine completionb 1.57 1.65 .54 .59
Mother encourages vaccine completionb 1.19 1.42 1.75 .08
Dichotomous Correlatesd % series incomplete % series complete p value
Childcare would prevent return
 Yes 60.9 39.1 .870
 No 62.6 37.4
Transportation issues would prevent return
 Yes 78.5 21.5− .001
 No 57.0 43.0
Work schedule would prevent return
 Yes 78.1+ 21.9− .001
 No 55.7 44.3
Friends have been vaccinated
 Yes 66.4 33.6 .78
 No 68.0 32.0
Friends failed to complete full vaccine series
 Yes 69.4 30.6 .39
 No 62.1 37.9
a
Lower scores represent greater agreement with the statement
b
5 point agreement scale
c
6 point agreement scale
d
+ represents significantly higher frequencies based on standardized residual (≥2 or ≤ −2); - represents significantly lower frequencies based on 
standardized residual (≥2 or ≤ −2).
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Table 4
Multivariate Findings for Positive Intent to Complete the Vaccine Series (N = 308)
AORa 95% CI p value
Correlate
Sexually experienced 6.62 1.61–34.48 .026
Ever had abnormal Pap test result 3.05 1.53–6.06 .002
3 doses decreases my cervical cancer risk 1.42 1.09–1.87 .011
HPV vaccine will reduce number of cervical cancer cases 1.75 1.23–2.50 .002
Would return with provider phone call 1.40 1.09–1.81 .009
Father encourages vaccine completion 0.72 0.54–0.95 .019
Work schedule would not prevent return 3.97 2.07–7.60 .001
Childcare would not prevent return 5.94 1.54–22.89 .010
Note. AOR=adjusted odds ratio; CI=confidence interval.
a
Odds ratio adjusted for all other variables in the model
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Table 5
Multivariate Findings for Completion of Vaccine Series (N = 336)
AORa 95% CI p value
Predictor Variable
Ever had abnormal Pap test result 1.20 0.73–1.99 .466
Intend to complete the series 2.07 1.15–3.76 .016
Would return if friend came with me 1.29 1.06–1.56 .011
3 doses decreases my cervical cancer risk 1.49 1.18–1.87 .001
Randomized to intervention condition 2.44 1.47–4.05 .001
Note. AOR=adjusted odds ratio; CI=confidence interval.
a
Odds ratio adjusted for all other variables in the model
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